A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Conditions: Osteosarcoma; Sarcoma; Soft Tissue Sarcoma; Bone Tumor Interventions: Drug: Recombinant oncolytic herpes simplex virus type Ⅰ (R130) Sponsors: Shanghai Yunying Medical Technology; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Hand Sanitizer Use for Herpes Simplex Virus-1
Conditions: Virus; HSV-1; Herpes Simplex 1; Herpes Simplex Labialis Interventions: Drug: Purell Hand Sanitizer; Drug: Medical Grade Mineral Oil Sponsors: Leciel Bono Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL
Conditions: Pneumonia, Viral; Ventilator Associated Pneumonia; Community-acquired Pneumonia; Herpes Simplex; Hospital-acquired Pneumonia Interventions: Drug: Acyclovir Sponsors: Jena University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Efficacy of Lazolex ® Gel in the Treatment of Herpes Simplex
Conditions: HSV Infection Interventions: Drug: walnut extract Sponsors: Iveriapharma LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Condition: Genital Herpes Interventions: Biological: mRNA-1608; Biological: BEXSERO Sponsor: ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Conditions: Sarcoma; Carcinoma; Digestive Cancer; Breast Cancer; Lung Cancer; Brain Cancer; Melanoma; Gynecologic Cancer; Head and Neck Cancer; Kidney Cancer Intervention: Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors: Shanghai Yunying Medical Technology; Linyi Central Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
